tiprankstipranks
Trending News
More News >
Cutia Therapeutics (HK:2487)
:2487
Hong Kong Market

Cutia Therapeutics (2487) Income Statement

Compare
2 Followers

Cutia Therapeutics Income Statement

Last quarter (Q2 2025), Cutia Therapeutics's total revenue was ¥66.29M, an increase of 93.02% from the same quarter last year. In Q2, Cutia Therapeutics's net income was ¥-239.39M. See Cutia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 279.62M¥ 137.62M¥ 11.37M¥ 2.04M
Gross Profit
¥ 143.46M¥ 71.01M¥ 7.94M¥ 1.61M
Operating Expenses
¥ 598.61M¥ 597.98M¥ 317.14M¥ 181.59M
Depreciation and Amortization
¥ 30.85M¥ 42.48M¥ 18.92M¥ 9.79M
EBITDA
¥ -430.69M¥ -1.92B¥ -535.19M¥ -309.23M
Operating Income
¥ -455.15M¥ -539.65M¥ -309.20M¥ -179.99M
Other Income/Expenses
¥ 21.34M¥ -1.42B¥ -246.63M¥ -139.60M
Pretax Income
¥ -433.81M¥ -1.96B¥ -555.84M¥ -319.58M
Net Income
¥ -433.81M¥ -1.96B¥ -555.84M¥ -319.58M
Per Share Metrics
Basic EPS
¥ -1.41¥ -6.43¥ -6.94¥ -3.99
Diluted EPS
¥ -1.41¥ -9.60¥ -6.94¥ -3.99
Weighted Average Shares Outstanding
307.19M 305.20M 80.05M 80.05M
Weighted Average Shares Outstanding (Diluted)
307.19M 305.20M 80.05M 80.05M
Currency in CNY

Cutia Therapeutics Earnings and Revenue History